Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Flavonoids can help heal wounds effectively due to their beneficial properties.

Targeting cellular senescence may improve skin aging and disorders.

Genes related to calcium signaling and lipid metabolism are important for curly hair in Mangalitza pigs.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

JAK inhibitors show promise for treating various skin diseases.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.